ShareThis Page
Business Briefs

Bayer agrees to $9B divestiture in Monsanto merger

| Tuesday, May 29, 2018, 5:48 p.m.
Bayer AG has agreed, Tuesday, May 29, 2018, to the U.S. government's demand that it sell about $9 billion in agriculture businesses as condition for acquiring Monsanto Co.
Associated Press
Bayer AG has agreed, Tuesday, May 29, 2018, to the U.S. government's demand that it sell about $9 billion in agriculture businesses as condition for acquiring Monsanto Co.

WASHINGTON — German pharmaceutical giant Bayer AG has agreed to the U.S. government's demand that it sell about $9 billion in agriculture businesses as a condition for acquiring Monsanto Co., an American seed and weed-killer maker.

Antitrust regulators at the Justice Department say it's the biggest divestiture ever required for a merger. The regulators say they directed Bayer to divest assets such as vegetable oils, seeds and seed treatments to ensure fair competition in the market after the massive agriculture business deal goes through. The assets will be sold to BASF, a German chemical company.

Bayer's $57 billion takeover of Monsanto has been watched by competitors and environmental groups, which are fearful that the number of players in the business of selling seeds and pesticides will shrink further and give a single company an exclusive grip on the food chain.

Monsanto, based in St. Louis, is one of the world's biggest seed companies. The merger would make Bayer the largest supplier in the world of pesticides and seeds for farmers.

The divestiture proposal will be filed in federal court and opened to public comment for 60 days.

In March, the European Union approved the merger on condition that Bayer sell $7.4 billion in assets to BASF to eliminate overlaps in seed and pesticide markets. The U.S. Justice Department said after the European action that it continued to have concerns over the proposed merger, especially its potential impact on American farmers and consumers, which could differ from its effects in Europe. Genetically modified seeds, for example, are used widely in the U.S. but are mostly banned in Europe.

The merger also has won approval from China, Brazil and Australia.

Bayer said it has now secured nearly all the needed government clearances for closing the deal.

“Receipt of the (Justice Department's) approval brings us close to our goal of creating a leading company in agriculture,” Bayer CEO Werner Baumann said in a statement. “We want to help farmers across the world grow more nutritious food in a more sustainable way.”

Some antitrust experts had warned that the merger would eliminate direct competition between two of the biggest players in the seed industry, giving the new company lopsided control over U.S. cotton acreage, and commercial seed development for canola, soybean and corn.

Two big mergers last year already have reshaped the global seed and pesticide market: Dow Chemical's combination with DuPont last year, and China National Chemical Corp.'s acquisition of Syngenta, a Swiss seed and pesticide maker.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

click me